XMEX
MEDICAB
Market cap311mUSD
Oct 08, Last price
52.50MXN
1D
0.00%
1Q
-11.62%
Jan 2017
24.11%
Name
Medica Sur, S.A.B. De C.V.
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Médica Sur, S.A.B. de C.V. functions as a leading healthcare provider within Mexico. The institution furnishes a comprehensive array of medical and surgical treatments, including intricate procedures such as bypass and gastric banding, cholecystectomy, inguinal hernia repair, liposculpture, breast augmentation, stereotactic radiosurgery, hip arthroplasty, knee and shoulder arthroscopy, spinal operations, lithiasis removal, and various prostate interventions, notably radical prostatectomy. Beyond these surgical offerings, Médica Sur also extends its services to include advanced radiotherapy, diagnostic imaging, comprehensive health check-ups, and medical insurance solutions. Established in 1966, this entity is headquartered in Mexico City and operates as a subsidiary of Neuco, SA de CV.
Key people
Misael Uribe Esquivel
Chairman of the Board, Executive President
Marisol Vazquez-Mellado Mollon
Chief Financial and Administrative Officer · since 2016
Jose Manuel Correa Rovelo
Chief Operating Officer · since 2016
Jorge Agustin Arredondo Reyna
Director of Systems and Information Technology
Cuauhtemoc Rafael Santa-Ana Otero
Interim Legal Director, Secretary · since 2018
Jorge Marcos Martinez
Director of Sales
Concepcion Guadalupe Arriaga Ruiloba
Director of Marketing, Communication and Special Events
Omar Herrera Garcia
Director of Human Resources
Ruben Diaz Cruz
Director of Internal Audit
Martha Helena Ramos Ostos
Director of CIDyT
Genaro Borrego Estrada
Director · since 2017
Fernando Bernardo Gabilondo Navarro
Director
Octavio Gonzalez Chon
Medical Director, Director
Juan Carlos Griera Hernando
Chief Executive Officer, Director · since 2017
Santiago Chico Servitje
Director, Laboratory Director · since 2016
Mario Federico Sicilia Benard
Director · since 2017
Santiago Casanueva Perez
Independent Director · since 2016
Xochitl Castaneda
Independent Director · since 2014
Juan Ramon de la Fuente Ramirez
Independent Director · since 2014
Daniel Antonio del Rio Loaisa
Independent Director · since 2014
Valuation
Title MXN in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||